Equivalent Efficacy but Different Safety Profiles of Gemcitabine Plus Nab-Paclitaxel and FOLFIRINOX in Metastatic Pancreatic Cancer

FOLFIRINOX (FFX) and gemcitabine + nab-paclitaxel (GN) are the most common chemotherapy regimens in first-line treatment of metastatic pancreatic cancer (PC). They have not been compared each other in a prospective trial, but only in retrospective studies, which can thus be affected by several biase...

Descripción completa

Detalles Bibliográficos
Autores principales: Rapposelli, Ilario Giovanni, Casadei-Gardini, Andrea, Vivaldi, Caterina, Bartolini, Giulia, Bernardini, Laura, Passardi, Alessandro, Frassineti, Giovanni Luca, Massa, Valentina, Cucchetti, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224606/
https://www.ncbi.nlm.nih.gov/pubmed/34067288
http://dx.doi.org/10.3390/biom11060780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224606/
https://www.ncbi.nlm.nih.gov/pubmed/34067288
http://dx.doi.org/10.3390/biom11060780

Ejemplares similares